To provide anti-NGF antibodies (such as anti-NGF antagonist antibodies), and polynucleotides encoding the same, for the treatment and/or prevention of pain, including post-surgical pain, rheumatoid arthritis pain, and osteoarthritis pain.
The invention relates to the anti-nerve growth factor (NGF) antibody wherein the antibody, (a) binds NGF with a KD of less than about 2 nM, (b) inhibits human NGF-dependent survival of mouse E13.5 trigeminal neurons with an IC50 of about 100 pM or less, wherein the IC50 is measured in the presence of about 15 pM human NGF, and (c) inhibits human NGF-dependent survival of mouse E13.5 trigeminal neurons with an IC50 of about 10 pM or less, wherein the IC50 is measured in the presence of about 1.5 pM of human NGF.
PONS JAUME
ROSENTHAL ARNON
JPH06510671A | 1994-12-01 |
BIOTECHNOLOGY, (1992), 10, [7], P.779-783, JPN6008006994, ISSN: 0000991437
PROC. NATL. ACAD. SCI. USA, (1994), 91, [9], P.3809-3813, JPN6008006999, ISSN: 0000991438
GENE, (1996), 169, [2], P.147-155, JPN6008007005, ISSN: 0000991439
J. IMMUNOL., (1995), 155, [4], P.1994-2004, JPN6008007011, ISSN: 0000991440
J. IMMUNOL., (1995), 154, [7], P.3310-3319, JPN6008007019, ISSN: 0000991441
J. MOL. BIOL., (1992), 226, [3], P.889-896, JPN6008007084, ISSN: 0000991442
IMMUNOL. TODAY, (1993), 14, [6], P.243-246, JPN6008055244, ISSN: 0001169666
J. MOL. BIOL., (1992), 224, [2], P.487-499, JPN6008055243, ISSN: 0001169665
Next Patent: METHOD FOR IMPROVING PROTEIN